Resmed CDI (ASX:RMD)
share price: (EoD)
earnings per share:
dividends per share:
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
Resmed CDI (ASX:RMD) share price
Resmed CDI (ASX:RMD) passive income
Resmed CDI (ASX:RMD) share price news
ALL ORDINARIES Index Higher, AMP (ASX:AMP) Shares Drop
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX: XAO), is currently up 0.40% at lunch.
Did You See ResMed’s (ASX:RMD) Latest Takeover?
This week, ResMed Inc. (ASX:RMD) announced it will be acquiring MatrixCare for US$750 million.
ALL ORDINARIES Index Up, Amcor (ASX:AMC) Shares Rise
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.24% at lunch.
Investors Breathe Easy On ResMed Inc (ASX:RMD) First Quarter Result
ResMed Inc (ASX:RMD) has reported its result for the first quarter of the 2019 financial year.
S&P/ASX 200 News Friday
Here are the stories from the S&P/ASX 200 (INDEXASX:XJO)(ASX:XJO) and Australian finance circles on Friday.
ALL ORDINARIES Index Up, CSL Shares Rise
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.34% at lunch.
Did You See The ResMed Inc (RMD) Report?
ResMed Inc. (ASX:RMD) shares have opened down 1.56% after the sleep apnea business reported its fourth quarter and FY18 result.
S&P/ASX 200 Pre Market News
Here are the headlines from the S&P/ASX 200 (INDEXASX:XJO)(ASX:XJO) and Australian finance circles on Thursday morning.
SomnoMed Limited (SOM) Revenues Jump 30%
SomnoMed Limited (ASX:SOM) today reported it achieved 30% revenue growth in its 2018 financial year.